Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma.
Rosario AscheroDaiana GaniewichGabriela LamasCamilo A Restrepo-PerdomoDaniela OttavianiSantiago ZugbiSandra CamareroEzequiel NéspoliMaria Cuadrado VilanovaSara Perez-JaumeGuillem Pascual-PastoClaudia SamporNathalia GrigorovskiBeatriz SalasMariona SuñolAngel M CarcabosoJaume MoraMaría T G de DávilaFrançois DozFrançois RadvanyiDavid H AbramsonAndrea S LleraPaula S SchaiquevichFabiana LubienieckiGuillermo L ChantadaPublished in: Pediatric blood & cancer (2023)
Expression of TFF1, especially when it is not-mutually exclusive with ARR3, is an independent significant marker of poor outcome in retinoblastoma.
Keyphrases